<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Medical and Human Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F0A3F403-8578-47AC-A520-9E6B1EDFC18F"><gtr:id>F0A3F403-8578-47AC-A520-9E6B1EDFC18F</gtr:id><gtr:firstName>Bill</gtr:firstName><gtr:surname>Deakin</gtr:surname><gtr:orcidId>0000-0002-2750-962X</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/06EE5A67-AAAF-4775-ABC4-A83EECD2DF5B"><gtr:id>06EE5A67-AAAF-4775-ABC4-A83EECD2DF5B</gtr:id><gtr:firstName>Rebecca</gtr:firstName><gtr:surname>Elliott</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6679837D-2DCF-4E69-9FCA-50883437109C"><gtr:id>6679837D-2DCF-4E69-9FCA-50883437109C</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:surname>Anderson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/96AF86E5-4DB9-45E1-AD8B-5B626D6DB524"><gtr:id>96AF86E5-4DB9-45E1-AD8B-5B626D6DB524</gtr:id><gtr:firstName>Prunwat</gtr:firstName><gtr:surname>Bijral</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A3A30F18-A6F8-4B74-B278-5545DF8790F5"><gtr:id>A3A30F18-A6F8-4B74-B278-5545DF8790F5</gtr:id><gtr:firstName>Lesley</gtr:firstName><gtr:surname>Peters</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802663"><gtr:id>44D3CCBE-8685-4F6E-93E3-71090E34B3D8</gtr:id><gtr:title>Neurobiology of cognition and craving in opiate addiction: implications for relapse</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0802663</gtr:grantReference><gtr:abstractText>Drug addiction is a serious social problem, placing a burden on health and social services as well as the criminal justice system. Although only a minority of addicts use heroin, it is associated with some of the most significant health and social costs of drug misuse. Effective treatments of drug addiction have proved elusive. One major reason for this is that although many addicts can overcome their addiction for a short period of time, their craving for opiates continues and leads to most relapsing in the long term. This research will investigate the brain mechanisms of craving and cognition in recently abstinent opiate addicts. It will also determine whether differences in brain function can predict whether individual addicts will relapse after discharge from a treatment programme. If key differences can be identified, this could provide the basis for the development of more effective treatments. We will provide information about our findings to the media, to users groups and on our website.</gtr:abstractText><gtr:technicalSummary>High rates of relapse are a key challenge in the treatment of opiate addiction. This proposal aims to bring new clinical and neuroscientific expertise to bear on the problem of understanding and preventing relapse. The initial aim is to establish the collaboration and to identify brain mechanisms that are associated with risk of relapse in recently de-toxified heroin addicts. Participants will be exposed to a video that reliably elicits subjective craving, during MRI scanning. Our novel phMRI analysis methods will enable us to follow the direct effects of craving on regional brain function for 15 minutes and then investigate how craving modulates cognitive function. The cognitive tasks will be chosen to challenge key processes implicated in addiction and risk of relapse; behavioural inhibition, cognitive control and decision-making. 40 opiate addicts will be recruited from an inpatient treatment programme and will be scanned as they complete the programme, just prior to discharge. At this stage, subjects will be abstinent from drugs and not taking maintenance medications. Subjects will be scanned twice at an interval of 48-72 hours to compare the effects of a craving video with a neutral video. A group of matched control subjects will be scanned using the same protocol. This will allow us to identify neuronal correlates of acute craving in opiate addicts, and the modulation of cognitive function by craving. The detoxified addicts will be monitored for 3 months following discharge from treatment to determine whether or not they relapse within this period. Based on experience and previous literature we anticipate a relapse rate of 50-70%. We will perform a post-hoc comparison between relapsing and abstinent patients to determine whether any of the neuronal indices represent potential biomarkers for relapse. This research will provide a basis for the use of imaging and cognitive biomarkers to detect the efficacy of novel pharmacological and psychological interventions to prevent relapse in opiate addicts.</gtr:technicalSummary><gtr:fund><gtr:end>2012-02-29</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>249619</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>&quot;Meet the scientist&quot; at MOSI</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>EB0DACF8-3BFC-46CC-B89E-DBE7C5775435</gtr:id><gtr:impact>In total over 1000 members of the public have attended 4 &amp;quot;meet the imaging scientist&amp;quot; events where these MRC projects were among the example applications discussed.

Increased awareness of biomedical imaging research.</gtr:impact><gtr:outcomeId>DWSXAxmfRsY</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mental health research network annual meeting, Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F3DAAAED-535C-4A1B-879E-465C76A248C2</gtr:id><gtr:impact>The talk was presented at the annual meeting of the Mental Health Research Network, attended by health professionals and service user groups. The talk elicited questions and discussion, as well as positive feedback. The talk was highlighted in the publication circulated by the MHRN after the event.

None</gtr:impact><gtr:outcomeId>TGTjBQUuR4s</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>&quot;Pint of Science&quot; festical, Manchester</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>42A8E1D8-E7C0-4F30-B8EF-EF7A7DB3BCC0</gtr:id><gtr:impact>Approximately 75 people attended an informal evening event with a series of talks, activities and discussion on the theme of addictions</gtr:impact><gtr:outcomeId>58bfdf14cf28a3.37721966</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://pintofscience.co.uk/events/manchester</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visits (Cheshire, Manchester and Bolton)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>4B75909A-468A-4DF1-8ED0-0932FFA051F1</gtr:id><gtr:impact>Six events, all using key examples from work supported by 2 MRC grants (as assigned).

In Manchester 120 year 11 pupils attended a talk on brain imaging and mental health and asked questions, discussed issues afterwards. The same talk to Bolton schools was attended by 60 year 11 students. In Cheshire, 20 A level Psychology students attended an hour long talk on this topic on three successive occasions and 16 of them subsequently visited me and post-docs working on these projects at work to hear more about the research on an individual basis.

Several A level students reported that the visit helped them decide to choose to apply to university to study psychology/neuroscience.</gtr:impact><gtr:outcomeId>AuhoeMDatLw</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011,2012,2013,2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1900000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Strategic Award (David Nutt PI)</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>656312D6-3930-4015-8CEB-CCA23221C9EF</gtr:id><gtr:outcomeId>bvRbWo6wXNV0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C41D3C28-9A1D-405E-A4C8-0166C072D89F</gtr:id><gtr:title>Time-dependent neuronal changes associated with craving in opioid dependence: an fMRI study.</gtr:title><gtr:parentPublicationTitle>Addiction biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27fcd60488447ec2442bd8cacdc63faa"><gtr:id>27fcd60488447ec2442bd8cacdc63faa</gtr:id><gtr:otherNames>Murphy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1355-6215</gtr:issn><gtr:outcomeId>5a2fd5cebafe45.83743893</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>020BA338-135F-4B1A-8636-08D1EBF85A07</gtr:id><gtr:title>The detrimental effects of emotional process dysregulation on decision-making in substance dependence.</gtr:title><gtr:parentPublicationTitle>Frontiers in integrative neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27fcd60488447ec2442bd8cacdc63faa"><gtr:id>27fcd60488447ec2442bd8cacdc63faa</gtr:id><gtr:otherNames>Murphy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1662-5145</gtr:issn><gtr:outcomeId>B85HjUagHvH</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802663</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>